BEONE MEDICINES UNITED KINGDOM, LTD.
Get an alert when BEONE MEDICINES UNITED KINGDOM, LTD. files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
—
Latest balance sheet
Net assets
£53K
0% vs 2023
Employees
0
Average over period
Profit before tax
—
Period ending 2024-12-31
Net assets
3-year trend · vs Unclassified median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2024-12-31
| Metric | Trend | 2020-12-31 | 2023-12-31 | 2024-12-31 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | — | — | — | — | |
| Operating profit | — | — | — | — | |
| Profit before tax | — | — | — | — | |
| Net profit | — | £0 | £0 | — | |
| Cash | — | — | — | — | |
| Total assets less current liabilities | £100 | £52,729 | £52,729 | 0% | |
| Net assets | — | £52,729 | £52,729 | 0% | |
| Equity | £100 | £52,729 | £52,729 | 0% | |
| Average employees | 0 | 0 | 0 | — | |
| Wages | — | — | — | — | |
| Directors' remuneration | — | £0 | £0 | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Name history
Renamed 1 time since incorporation
- BEONE MEDICINES UNITED KINGDOM, LTD. 2025-05-13 → present
- BEIGENE UNITED KINGDOM, LTD. 2019-08-19 → 2025-05-13
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Ernst & Young LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The directors have assessed the financial position and likely future cash flows of the Company at the date of approving these financial statements. The directors noted that the Company has net assets of £52,729. The Company's result is nil. As such, the ultimate parent BeOne Medicines Ltd, has confirmed through a letter of support that it will ensure that sufficient funds are available so that the Company can continue to meet its obligations until 31 December 2026.”
Group structure
- BEONE MEDICINES UNITED KINGDOM, LTD. · parent
- Beigene (Canada) ULC 100%
- Beigene NZ Unlimited 100%
- BeiGene (Thailand) Ltd. 0.01%
- BeiGene Argentina S.R.L. 4.72%
- Beigene Mexico 5%
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
2 active · 3 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| HARRIS, James Edwards | Director | 2024-08-01 | Oct 1979 | British |
| MULROONEY, Robert Dominic | Director | 2023-08-09 | Apr 1961 | Irish |
Show 3 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| DUSORUTH, Devun | Director | 2023-08-09 | 2025-02-21 |
| MALLER, Daniel Robert | Director | 2019-08-19 | 2023-08-09 |
| SAMUELS, Scott Alan | Director | 2019-08-19 | 2022-06-30 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Beone Medicines Uk, Ltd. | Corporate entity | Significant influence | 2019-08-19 | Active |
Filing timeline
Last 20 of 30 total filings
Material constitutional events — rename, articles re-file, resolution
- 2025-05-13 CERTNM Certificate change of name company PDF
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2025-10-27 | AA | accounts | Accounts with accounts type full | |
| 2025-08-26 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2025-05-13 | CERTNM | change-of-name | Certificate change of name company | |
| 2025-05-12 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2025-03-04 | TM01 | officers | Termination director company with name termination date | |
| 2024-10-12 | AA | accounts | Accounts with accounts type full | |
| 2024-08-29 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-08-01 | AP01 | officers | Appoint person director company with name date | |
| 2024-01-02 | AA | accounts | Accounts with accounts type small | |
| 2023-10-11 | CH01 | officers | Change person director company with change date | |
| 2023-10-11 | AD01 | address | Change registered office address company with date old address new address | |
| 2023-10-11 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2023-08-27 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-08-27 | AP01 | officers | Appoint person director company with name date | |
| 2023-08-27 | TM01 | officers | Termination director company with name termination date | |
| 2023-08-27 | AP01 | officers | Appoint person director company with name date | |
| 2022-09-28 | AAMD | accounts | Accounts amended with accounts type dormant | |
| 2022-08-31 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2022-08-19 | AA | accounts | Accounts with accounts type dormant | |
| 2022-07-10 | TM01 | officers | Termination director company with name termination date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 2
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.